Cytokine Release by Monocytes in Head and Neck Cancer
Author Information
Author(s): O. Gallo, A.M. Gori, M. Attanasio, F. Martini, B. Giusti, M. Boddi, E. Gallina, O. Fini, R. Abbate
Primary Institution: University of Florence
Hypothesis
The study investigates the production of interleukin 1 beta and interleukin 6 by peripheral blood monocytes in patients with head and neck cancer compared to healthy subjects.
Conclusion
The study found that monocytes from head and neck cancer patients produce significantly more IL-6 than those from healthy controls, while IL-1 beta production did not differ significantly.
Supporting Evidence
- Monocytes from cancer patients showed significantly higher IL-6 production compared to healthy controls.
- IL-1 beta production did not show significant differences between cancer patients and controls.
- 15 out of 22 cancer patients had IL-6 production outside the control range.
Takeaway
Patients with head and neck cancer have more of a substance called IL-6 in their blood, which might affect how their body fights the cancer.
Methodology
The study involved isolating monocytes from blood samples of cancer patients and healthy controls, then measuring IL-1 beta and IL-6 levels after stimulation with lipopolysaccharides.
Potential Biases
The study may have bias due to the selection of only male patients and the exclusion of those who received prior treatments.
Limitations
The study only included male patients and did not account for potential confounding factors such as other health conditions.
Participant Demographics
22 male patients aged 49 to 67 years with head and neck squamous cell carcinoma.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website